Common use of New Commitments Clause in Contracts

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 18 contracts

Samples: Cooperative Research and Development Agreement (Bavarian Nordic a/S / ADR), Material Transfer Agreement (Newlink Genetics Corp), And Development Agreement (Intercept Pharmaceuticals Inc)

AutoNDA by SimpleDocs

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 13 contracts

Samples: Research and Development Agreement, Research and Development Agreement, Cooperative Research and Development Agreement (Scopus BioPharma Inc.)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to one (1) year […***…] subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 6 contracts

Samples: Agreement (Tracon Pharmaceuticals, Inc.), Research and Development Agreement (Tracon Pharmaceuticals Inc), Research and Development Agreement (Kite Pharma, Inc.)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD CDC will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 4 contracts

Samples: Public Health Service, Public Health Service, Public Health Service

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, termination or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds for up to one five (15) year years subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 2 contracts

Samples: Public Health Service, Cooperative Research and Development Agreement

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, termination or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds for up to one (1) year […***…] years subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 2 contracts

Samples: Agreement (Tracon Pharmaceuticals, Inc.), Agreement (Tracon Pharmaceuticals Inc)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, termination or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD NCI will have the authority to retain and expend any funds for up to one five (15) year years subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 1 contract

Samples: Health Service

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination termination, and each Party will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds provided by the Collaborator during the term of this CRADA (if any) for up to one (1) year [*] subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 1 contract

Samples: Material Transfer Agreement (Newlink Genetics Corp)

AutoNDA by SimpleDocs

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, or mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds previously paid by Collaborator for up to one two and one-half (12.5) year years subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 1 contract

Samples: And Development Agreement (Exelixis, Inc.)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD FDA will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research PlanPIan.

Appears in 1 contract

Samples: Public Health Service (BG Medicine, Inc.)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to one (1) year [*] subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 1 contract

Samples: Public Health Service (Introgen Therapeutics Inc)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.. PHS CRADA Agreement Ref. No. 2020-12 MODEL ADOPTED June 18, 2009

Appears in 1 contract

Samples: Development Agreement (Virpax Pharmaceuticals, Inc.)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, termination or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD NCI will have the authority to retain and expend any necessary funds for up to one five (15) year years subsequent to the expiration or termination date to cover any unpaid unpaid, undisputed costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research PlanPlan in accordance with this CRADA.

Appears in 1 contract

Samples: Public Health Service

Time is Money Join Law Insider Premium to draft better contracts faster.